Special notice
Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Contract for Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity
HFP-2026-134390
Food and Drug Administration, FDA Office of Acq Grant SVCS. Other Scientific and Technical Consulting Services.
Response deadline
July 10, 2026 at 5:00 PM EDT
Closed 70 days ago. Posted July 5, 2026. Scheduled to archive July 25, 2026.
Description
As published on SAM.gov.
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price contract to Cyprotex US, LLC, 200 Staples Drive, Framingham, MA 01702, USA, incorporated for the purchase of Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity, in accordance with the authority under FAR Part 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements.
Cyprotex US, LLC is qualified for DT/OCT/OLOAS/HFP unique requirement because they are the only vendor that offers a neural network formation NAM which utilizes microelectrode array (MEA) technology that can be appropriately adapted for the agency specific needs. This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.
The North American Industry Classification System (NAICS) code for the proposed acquisition is 541690 - Other Scientific and Technical Consulting Services. Deliverables Raw experimental data, noting any deviations from standard procedure - Electronic file (.csv or .RData preferred) - Estimated Delivery Date - 01/31/27 Responses Responses to this notice should be sent to Haroon Gulzar at haroon.gulzar@fda.hhs.gov no later than 5:00 pm (ET) on July 10, 2026. This notice is not a request for competitive quotes.
Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 5, 2026
Special notice
Due July 10, 2026 at 5:00 PM EDT. SAM.gov, notice c2b7945e49114ba18dcdd25ce699fd7c
Points of contact
- Haroon Gulzarharoon.gulzar@fda.hhs.gov
- Craig Wrightcraig.wright@fda.hhs.gov
Also open from this buyer
- Walk-In Laboratory CoolerSolicitationNAICS 33341575F40126Q00386Closes todaySep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes todaySep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 3 daysSep 21
- Portable Force Plate System-Brand Name and Equal (BNE)Combined synopsis and solicitationNAICS 334519Silver Spring, MDRFQ-CDRH-2026-133635Closes in 3 daysSep 21
- Automated Liquid Handling PlatformPresolicitationNAICS 334516Silver Spring, MD75F40126Q00423Closes in 4 daysSep 22